Press release
Cardiac Prosthetic Devices Market is Projected to Reach USD 17.10 Billion by 2035
The global cardiac prosthetic devices market is set for steady and significant growth, with its valuation projected to rise from USD 8.41 billion in 2025 to USD 17.10 billion by 2035, reflecting a compound annual growth rate (CAGR) of 6.5%. This expansion is driven by the increasing prevalence of cardiovascular diseases (CVDs), an aging global population, and continuous technological advancements in cardiac care. Cardiac prosthetic devices, including pacemakers and heart valves, are essential for managing conditions like heart failure, arrhythmias, and valvular heart diseases, improving patient outcomes and quality of life. The market's growth underscores the rising demand for innovative, minimally invasive solutions that address the growing burden of heart-related ailments worldwide.For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7718
Market Segmentation and Trends:
The cardiac prosthetic devices market is segmented by product type, end user, and region, providing a comprehensive view of its dynamics. Product types include implantable pacemakers (28% market share in 2025), external pacemakers, transcatheter heart valves (25% share), tissue heart valves, and mechanical heart valves. Implantable pacemakers and transcatheter heart valves dominate due to their efficacy in treating arrhythmias and valvular diseases. End users encompass hospitals (55% share in 2025), specialty centers (20%), ambulatory surgical centers, and others, with hospitals leading due to their advanced infrastructure for complex procedures.
Regionally, North America holds the largest share, while Asia Pacific is witnessing rapid growth driven by healthcare investments. Key trends include the shift toward minimally invasive procedures like transcatheter aortic valve replacement (TAVR), the integration of AI for personalized treatments, and the development of bioresorbable and 3D-printed valves for improved biocompatibility and reduced complications.
Driving Factors Behind Market Growth:
Several factors are fueling the cardiac prosthetic devices market's growth. The rising incidence of CVDs, with over 17 million annual deaths globally, is a primary driver, particularly among the elderly population, which is projected to reach 1.5 billion by 2050. Technological advancements, such as leadless pacemakers and AI-enhanced diagnostic tools, are enhancing device precision and patient safety. Increasing healthcare investments in emerging regions, like Asia Pacific and Latin America, are improving access to advanced cardiac care.
Government initiatives for universal healthcare and awareness campaigns about heart health are boosting adoption. Additionally, the preference for minimally invasive surgeries, which reduce recovery time and risks, is driving demand for transcatheter and sutureless valves, further propelling market expansion.
Recent Developments and Key Players:
The cardiac prosthetic devices market is highly competitive, with key players focusing on innovation, regulatory approvals, and strategic partnerships to maintain market leadership. In February 2025, LivaNova PLC launched its Perceval Plus sutureless heart valve across Asia-Pacific, offering improved durability and ease of implantation for aortic valve replacement. Medtronic and Edwards Lifesciences have advanced TAVR systems, with Edwards' SAPIEN series gaining traction for high-risk patients. Other developments include the integration of AI for real-time device monitoring and the exploration of 3D-printed, patient-specific valves.
Key players include Edwards Lifesciences Corporation (20-25% market share), Abbott Laboratories (18-22%), Boston Scientific Corporation (15-20%), Medtronic plc (12-17%), Biotronik (8-12%), CryoLife, Inc., TTK Healthcare, Venus Medtech, Vitatron, Abiomed, Inc., AtriCure, Inc., Braile Biomedica, Labcor Laboratories, Lepu Medical Technology Co. Ltd., Lifetech Scientific, and others (combined 25-35%).
Competitor analysis reveals a focus on technological differentiation and geographic expansion. Established companies like Edwards and Abbott emphasize high-quality, premium products with strong clinical evidence, while smaller firms target emerging markets with cost-effective solutions. Strategies include mergers and acquisitions to bolster portfolios, such as integrating AI and robotic-assisted technologies, and collaborations with hospitals for clinical trials. Price competition is intense, with firms balancing innovation costs and affordability to capture diverse market segments.
Regional Insights and Opportunities:
North America dominates the cardiac prosthetic devices market, with the U.S. projected to reach USD 11.2 billion by 2035 at a 7.1% CAGR, driven by advanced healthcare systems and high CVD prevalence. Europe follows, with the UK (6.4% CAGR), France (5.9%), Germany (6.2%), and Italy (5.7%) benefiting from robust medical infrastructure. Asia Pacific is the fastest-growing region, led by China (USD 2.0 billion in 2025, 8.3% CAGR) and Japan (5.8% CAGR), fueled by aging populations and government healthcare initiatives. South Korea (6.5% CAGR), Australia (6.0%), and New Zealand (5.6%) also show strong potential. Latin America and the Middle East & Africa offer opportunities through public-private partnerships and mobile surgical units to address rural healthcare gaps.
Browse Full Report: https://www.factmr.com/report/cardiac-prosthetic-devices-market
Challenges and Future Outlook:
The cardiac prosthetic devices market faces challenges, including high costs of implants and procedures, limiting adoption in low-income regions, and reimbursement issues that affect accessibility. Rural areas often lack specialized cardiac care, exacerbating disparities. Regulatory hurdles and the need for extensive clinical trials can delay innovations. However, the market's future is promising, with opportunities in AI-driven personalization, bioresorbable materials, and expanded access in emerging markets. The focus on minimally invasive and connected devices will drive growth, improving outcomes for millions. By 2035, the market is set to thrive, supported by clinical needs, technological ingenuity, and global healthcare advancements.
Cardiac Patch Monitor Market: https://www.factmr.com/report/cardiac-patch-monitor-market
Cardiac Pacemaker Market: https://www.factmr.com/report/cardiac-pacemakers-market
Cardiac Marker Analyzer Market: https://www.factmr.com/report/cardiac-marker-analyzer-market
Cardiac Biomarkers Market: https://www.factmr.com/report/cardiac-biomarkers-market
Cardiac Resynchronization Therapy Market: https://www.factmr.com/report/cardiac-resynchronization-therapy-market
Cardiac Ablation Technologies Market: https://www.factmr.com/report/4426/cardiac-ablation-technologies-market
Cardiac Mapping System Market: https://www.factmr.com/report/1131/cardiac-mapping-system-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Prosthetic Devices Market is Projected to Reach USD 17.10 Billion by 2035 here
News-ID: 4177731 • Views: …
More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between…

Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032.
Market Drivers & Outlook
The demand for…

Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems.
Key…

Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…